Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria--a shadow over Africa.

Louis H Miller1, Brian Greenwood

  • 1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

Science (New York, N.Y.)
|October 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

medRxiv : the preprint server for health sciences·2026
Same author

The burden of malaria-attributable maternal anaemia and the impact of preventive treatment across sub-Saharan Africa.

Nature health·2026
Same author

Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial.

The Journal of infectious diseases·2026
Same author

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.

PLoS neglected tropical diseases·2026
Same author

Serological assessment of pediatric parasite exposure in two Senegalese districts using multiplex serology.

Current research in parasitology & vector-borne diseases·2025
Same author

Identification of age-group reservoirs for persistent vaccine-type pneumococcal carriage in rural Gambia.

Pneumonia (Nathan Qld.)·2025
Same journal

A native sulfur deposit in Gale crater, Mars.

Science (New York, N.Y.)·2026
Same journal

Coordinated demise of harmful algal blooms.

Science (New York, N.Y.)·2026
Same journal

Genetic effects put into context.

Science (New York, N.Y.)·2026
Same journal

Bacteria share proteins to survive antibiotics.

Science (New York, N.Y.)·2026
Same journal

Impacts shaped Earth's first continents.

Science (New York, N.Y.)·2026
Same journal

Erratum for the Report "Covalently bonded single-molecule junctions with stable and reversible photoswitched conductivity" by C. Jia <i>et al</i>.

Science (New York, N.Y.)·2026
See all related articles

New public health tools are needed to reduce severe malaria and deaths in Africa. Genome sequencing of Plasmodium falciparum and Anopheles gambiae offers a pathway to discovering these essential malaria control measures.

Area of Science:

  • Genomics
  • Parasitology
  • Vector Biology

Background:

  • Falciparum malaria remains a significant cause of severe disease and mortality in Africa.
  • Existing public health interventions require enhancement with more effective and affordable tools.
  • The development of novel strategies is crucial for malaria control and elimination efforts.

Purpose of the Study:

  • To highlight the importance of genomic resources for developing new malaria control tools.
  • To emphasize the potential of Plasmodium falciparum and Anopheles gambiae genome data in discovering innovative public health measures.
  • To underscore the need for advanced tools to combat malaria in Africa.

Main Methods:

  • Genome sequencing of Plasmodium falciparum (malaria parasite).

Related Experiment Videos

  • Genome sequencing of Anopheles gambiae (malaria vector).
  • Bioinformatic analysis of genomic data to identify potential targets for intervention.

    • Main Results:

    • The completion of the Plasmodium falciparum genome provides a blueprint for understanding parasite biology.
    • The Anopheles gambiae genome sequence offers insights into vector behavior and susceptibility.
    • These genomic resources are foundational for discovering novel diagnostics, therapeutics, and vector control strategies.

    Conclusions:

    • Completed genome sequences of Plasmodium falciparum and Anopheles gambiae are pivotal advancements.
    • These genomic datasets are essential for the rational design of new, cost-effective public health tools.
    • Leveraging genomic information is key to reducing the burden of falciparum malaria in Africa.